Our Mission
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy.
Latest News
-
24 June 2024
June 2024 Journal Watch Explores Topics in Pulmonology
-
21 June 2024
Board of Directors Nominations Due 5 July
-
20 June 2024
ISHLT Endorses 16th International Congress on Lung Transplantation
ISHLT now has an online store where you can purchase merch! Visit the ISHLT Store and check out the featured products, incljuding special ISHLT2024 items.
Shop the ISHLT StoreISHLTconnect is an online discussion platform open to anyone involved in the management and treatment of advanced heart and lung disease, transplantation, mechanical circulatory support, and pulmonary vascular disease. Members get complete access to all interdisciplinary discussion groups, while nonmembers can explore ten Professional Community boards.
Log InUpcoming Events
-
27 June, 2024 3:00 p.m. to 4:00 p.m. EDT
A Joint Venture for Defeating Infectious Threats Post-Transplantation: Pathologists and Microbiologists Together
Heart and lung transplant recipients are highly susceptible to conventional and opportunistic infections, which represent a major cause of morbidity, graft dysfunction and mortality. This session will examine the risk factors relevant to heart and lung transplant recipients, and the syndromes associated with them, such as respiratory failure, sepsis, and CNS infection. -
28 June, 2024 10:00 a.m. to 11:00 a.m. EDT
Chopin’s Etude in CMV Major
CMV remains a significant challenge in solid organ transplant recipients, with impact on allograft function and toxicities related to treatment. This session will allow for discussion of new approaches to prevention, prophylaxis, treatment, and patient risk stratification. -
29 June to 1 July, 2024
7th World Symposium on Pulmonary Hypertension
The PH World Symposia series has marked the progress in pulmonary hypertension science and has identified fruitful directions for future developments. The published supplements, including the symposia proceedings, constitute a collection of articles among the most cited in this scientific area.Barcelona, Spain
and Lung Transplantation